Evaluation of presepsin as a diagnostic tool in newborns with risk of early-onset neonatal sepsis

ObjectivesTo evaluate the efficacy of presepsin (P-SEP) as a potential biomarker of early-onset neonatal sepsis (EOS) and compare it to other routinely used markers of inflammation. To establish the cut-off values of P-SEP for EOS.Study design184 newborns were prospectively recruited between January...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Iva Pospisilova (Egilea), Helena L. Brodska (Egilea), Marketa Bloomfield (Egilea), Klara Borecka (Egilea), Jan Janota (Egilea)
Formatua: Liburua
Argitaratua: Frontiers Media S.A., 2023-01-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak